Published on 9 Nov 2022 on Zacks via Yahoo Finance
Pliant Therapeutics, Inc. (PLRX) Reports Q3 Loss, Misses Revenue Estimates
Pliant Therapeutics, Inc. (PLRX) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.74. This compares to loss of $0.75 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 12.16%. A quarter ago, it was expected that this company would post a loss of $0.82 per share when it actually produced a loss of $0.82, delivering no surprise.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.